In-Vitro Diagnostics Market, Saudi Arabia (By Technology, Application, Product, End User), Size, Share, Major Deals, Government Initiatives, Key Company Profiles, Revenue, Recent Developments - Forecast to 2030

Saudi Arabia In-Vitro Diagnostics Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Government Initiatives, Key Company Profiles, Revenue, Recent Developments - Forecast to 2030

Saudi Arabia in-vitro diagnostics market is predicted to reach US$ 1,195 Million by 2030, from US$ 780 Million in 2023. Saudi Arabia is the largest market for in-vitro diagnostics in the GCC region. As in other countries, Saudi Arabia is facing the challenges of fighting with infectious disease including HBV, TB, HCV and HIV, as well as various chronic diseases and cancer. In-vitro diagnostics plays an important role in the detection of infectious and chronic diseases. In-vitro diagnosis refers to the diagnosis of diseases or other condition of the human body through the collection, preparation, and testing of human samples with reagents, instruments, and systems.

The rising geriatric population and the high burden of chronic and infectious diseases propels the growth of Saudi Arabia in-vitro diagnostics market, as these chronic disorders can be diagnosed and monitored using in-vitro diagnostics (IVD) products. Moreover, Saudi Arabian government is taking number of initiatives to improve the healthcare sector in the country. For instance, Under Vision 2030, the Saudi Arabian Government plans to invest over US$ 65 Billion to develop the country’s healthcare infrastructure. The government has set the target of privatizing 290 hospitals and 2,300 primary health centers by 2030. Furthermore, the government seeks to improve the country’s healthcare sector by adopting digital information systems.

Recent Developments

In January 2024, bioMérieux announced the acquisition of LUMED, a software company that has developed a clinical decision support system to help hospitals optimize antimicrobial prescriptions and monitor healthcare-associated infections.
In August 2023, Sysmex Corporation announced an expansion of the Global Business Partnership Agreement (GBPA) with Roche Diagnostics International Ltd.
In February 2023, Unilabs announced investing over US$ 200 million in Siemens Healthineers' technology and acquiring more than 400 laboratory analyzers to strengthen its laboratory infrastructure.

By Technology: Saudi Arabia IVD Market – Key Takeaways

On technology basis, Immunoassay and Clinical Chemistry are the leading segment of the Saudi Arabia IVD market. Together they contributed nearly 60 percent to the total Saudi Arabia IVD market in 2023.
Molecular Diagnostics accounted for nearly 10 percent share of the Saudi Arabia IVD market in 2023.
POCT and SMBG segments are competing closely to grab maximum market share of the pie. POCT is transforming diagnostic practices through its convenience and efficiency.
The growth of hematology market is attributed to factors such as the increasing incidences of blood disorders, growing adoption of automated hematology instruments by diagnostic laboratories, the emergence of high throughput hematology analyzers, and the introduction of technologically advanced hematology instruments.
Microbiology testing is witnessing growth due to technological advancements and increasing infectious disease incidences.

By Application: Saudi Arabia IVD Market – Key Takeaways

On the basis of application, Infectious diseases and Diabetes are the leading segments of the Saudi Arabia IVD market. Together they contributed around 55 percent to the total Saudi Arabia IVD market in 2023.
The Saudi Government has set a goal to increase life expectancy from 75 to 80 years of age. This will be achieved primarily by addressing the disease burden of noncommunicable diseases in the country, such as cardiovascular disease (CVD).
Oncology application segment held 3rd highest share of the Saudi Arabia IVD market in 2023, followed by cardiovascular diseases.
Autoimmune Diseases was responsible for single digit share of the Saudi Arabia IVD market in 2023, while Nephrology held least share of the Saudi Arabia IVD market.

By Product: Saudi Arabia IVD Market – Key Takeaways

Reagents held largest share of the Saudi Arabia IVD market in 2023 and is expected to remain dominant over the forecast period, since reagents are a vital part of every in-vitro diagnostics test.
The instruments segment was responsible for a quarter share of the Saudi Arabia IVD market in 2023. The introduction of advanced instruments offers an excellent avenue for the segment's growth.
The software and services held least share of the Saudi Arabia IVD market.

By End User: Saudi Arabia IVD Market – Key Takeaways

Government Labs & Hospitals held largest share of the Saudi Arabia IVD market in 2023, owing to large volume of diagnostic tests carried out in these settings.
Private Labs & Hospitals contributed nearly a quarter to the overall Saudi Arabia IVD market.
Saudi Arabian government has set the target of privatizing 290 hospitals and 2,300 primary health centers by 2030, under the Saudi Vision 2030 Plan.

Saudi Arabia IVD Market - Key Company Profiles

Roche diagnostics division revenue declined to US$ 15,677 Million in 2023, following the sharp decline in demand for COVID-19-related tests.
In diagnostics business, Abbott's focus will be on driving sales growth from its Alinity suite of diagnostics instruments and its portfolio of rapid diagnostic testing system.
In August 2023, Sysmex Corporation announced an expansion of the Global Business Partnership Agreement (GBPA) with Roche Diagnostics International Ltd.
In May 2023, Siemens Healthineers announced the launch of next-gen hematology analyzers: Atellica HEMA 570 Analyzer and the Atellica HEMA 580 Analyzer.

iGATE RESEARCH report titled “Saudi Arabia In-Vitro Diagnostics Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Government Initiatives, Key Company Profiles, Revenue, Recent Developments - Forecast to 2030” provides a comprehensive analysis of the Saudi Arabia In-Vitro Diagnostics (IVD) Market.

This 279 Pages report with 70 Figures and 8 Tables has been analyzed from 10 View Points:

1) Saudi Arabia In-Vitro Diagnostics Market and Forecast (2018 - 2030)
2) Saudi Arabia In-Vitro Diagnostics Market Share and Forecast (2018 - 2030)
3) By Technology - Saudi Arabia In-Vitro Diagnostics Market & Forecast (2018 - 2030)
4) By Application - Saudi Arabia In-Vitro Diagnostics Market & Forecast (2018 - 2030)
5) By Product - Saudi Arabia In-Vitro Diagnostics Market & Forecast (2018 - 2030)
6) By End User - Saudi Arabia In-Vitro Diagnostics Market & Forecast (2018 - 2030)
7) Saudi Arabia In-Vitro Diagnostics Market - Key Company Profiles (2014 - 2030)
8) In-Vitro Diagnostics (IVD) Market - Major Deals
9) In-Vitro Diagnostics (IVD) Market - Recent Developments
10) Saudi Arabia In-Vitro Diagnostics - Market Dynamics

By Technology - Saudi Arabia IVD Market and Forecast

1. Immunoassay
2. Clinical Chemistry
3. Hematology
4. Coagulation/Hemostasis
5. Microbiology
6. Molecular Diagnostic
7. Self-Monitoring of Blood Glucose (SMBG)
8. Point of Care Testing (POCT)
9. Others

By Application - Saudi Arabia IVD Market and Forecast

1. Infectious Diseases
2. Cardiovascular Diseases
3. Diabetes
4. Oncology
5. Nephrology
6. Autoimmune Diseases
7. Others

By Product - Saudi Arabia IVD Market and Forecast

Reagents
Instruments
Software and Services

By End User - Saudi Arabia IVD Market and Forecast

Government Labs & Hospitals
Private Labs & Hospitals
Others

Saudi Arabia IVD Market - Key Players Analysis

1. Roche
2. Abbott
3. Sysmex Corporation
4. Danaher Corporation
5. Thermo Fischer Scientific Inc.
6. Siemens Healthineers
7. Biomerieux SA
8. Bio-Rad Laboratories, Inc
9. Becton Dickinson and Company
10. Nihon Kohden Corporation

Data Source

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies:

Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies:

Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.